{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T10:53:57Z","timestamp":1776768837103,"version":"3.51.2"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.transci.2019.03.013","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T13:08:04Z","timestamp":1552568884000},"page":"216-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["The contact system at the crossroads of various key patho- physiological functions: Update on present understanding, laboratory exploration and future perspectives"],"prefix":"10.1016","volume":"58","author":[{"given":"Jean","family":"Amiral","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerard","family":"Seghatchian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.transci.2019.03.013_bib0005","first-page":"3","article-title":"Blood coagulation","volume":"67","author":"Butenas","year":"2002","journal-title":"Biochem (Mosc) Suppl Ser A Membr Cell Biol"},{"issue":"November (22)","key":"10.1016\/j.transci.2019.03.013_bib0010","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1182\/blood-2012-07-292094","article-title":"In vivo roles of factor XII","volume":"120","author":"Renn\u00e9","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.transci.2019.03.013_bib0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12959-015-0048-y","article-title":"Contact pathway of coagulation and inflammation","volume":"13","author":"Wu","year":"2015","journal-title":"Thromb J"},{"key":"10.1016\/j.transci.2019.03.013_bib0020","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/jth.13235","article-title":"Contact system revisited: an interface between in\ufb02ammation, coagulation, and innate immunity","volume":"14","author":"Long","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.transci.2019.03.013_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/IBRR\/2016\/26906","article-title":"The cell based model of in-vivo coagulation: a work in progress","volume":"6","author":"Patri","year":"2016","journal-title":"Int Blood Res Rev"},{"issue":"January (1)","key":"10.1016\/j.transci.2019.03.013_bib0030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/jth.13194","article-title":"The contact activation and kallikrein\/kinin systems: pathophysiologic and physiologic activities","volume":"14","author":"Schmaier","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"November(11 Pt B)","key":"10.1016\/j.transci.2019.03.013_bib0035","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.bbamcr.2017.07.009","article-title":"The plasma contact system, a protease cascade at the nexus of inflammation, coagulation and immunity","volume":"1864","author":"Weidmann","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"March (3)","key":"10.1016\/j.transci.2019.03.013_bib0040","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1182\/blood.V65.3.719.719","article-title":"Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds","volume":"65","author":"Ragni","year":"1985","journal-title":"Blood"},{"issue":"Febuary (2)","key":"10.1016\/j.transci.2019.03.013_bib0045","first-page":"117","article-title":"Thromboembolism and bleeding tendency in congenital factor XII deficiency--a study on 74 subjects from 14 Swiss families","volume":"65","author":"L\u00e4mmle","year":"1991","journal-title":"Thromb Haemost"},{"issue":"Suppl. 1","key":"10.1016\/j.transci.2019.03.013_bib0050","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1538-7836.2009.03395.x","article-title":"Factor XI de\ufb01ciency in humans","volume":"7","author":"SELIGSOHN","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"July (7)","key":"10.1016\/j.transci.2019.03.013_bib0055","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/17474086.2016.1191944","article-title":"Why factor XI deficiency is a clinical concern","volume":"9","author":"Wheeler","year":"2016","journal-title":"Expert Rev Hematol"},{"issue":"April (2)","key":"10.1016\/j.transci.2019.03.013_bib0060","article-title":"Factor XII deficiency","volume":"7","author":"Baldua","year":"2017","journal-title":"RGUHS Med Sci"},{"issue":"August (8)","key":"10.1016\/j.transci.2019.03.013_bib0065","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/jth.13383","article-title":"Factor XII: form determines function","volume":"14","author":"de Maat","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.transci.2019.03.013_bib0070","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1182\/blood-2010-02-270918","article-title":"A role for factor XIIa\u2212mediated factor XI activation in thrombus formation in vivo","volume":"116","author":"Cheng","year":"2010","journal-title":"Blood"},{"issue":"October (14)","key":"10.1016\/j.transci.2019.03.013_bib0075","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1182\/blood-2011-03-339572","article-title":"Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin","volume":"118","author":"Konings","year":"2011","journal-title":"Blood"},{"issue":"May(5)","key":"10.1016\/j.transci.2019.03.013_bib0080","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1007\/s10439-016-1771-7","article-title":"Differential roles for the coagulation factors XI and XII in regulating the physical biology of fibrin","volume":"45","author":"Sylman","year":"2017","journal-title":"Ann Biomed Eng"},{"issue":"October (11)","key":"10.1016\/j.transci.2019.03.013_bib0085","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1084\/jem.20091007","article-title":"Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis","volume":"206","author":"Decrem","year":"2009","journal-title":"J Exp Med"},{"issue":"July (7)","key":"10.1016\/j.transci.2019.03.013_bib0090","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/jth.12302","article-title":"Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer","volume":"11","author":"Woodruff","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"July(7)","key":"10.1016\/j.transci.2019.03.013_bib0095","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1161\/ATVBAHA.113.301282","article-title":"Antithrombotic effect of antisense factor XI oligonucleotide treatment in primates","volume":"33","author":"Crosby","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"July (7)","key":"10.1016\/j.transci.2019.03.013_bib0100","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1161\/ATVBAHA.113.301598","article-title":"Targeting factor XI to prevent thrombosis","volume":"33","author":"Morrissey","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"April(4)","key":"10.1016\/j.transci.2019.03.013_bib0105","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1160\/TH13-08-0668","article-title":"Factor XIIa inhibition by Infestin-4: in vitro mode of action and in vivo antithrombotic benefit","volume":"1","author":"Xu","year":"2014","journal-title":"Thromb Haemost"},{"issue":"Febuary (222)","key":"10.1016\/j.transci.2019.03.013_bib0110","article-title":"A factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding risk","volume":"6","author":"Larsson","year":"2014","journal-title":"Sci Transl Med"},{"issue":"August (8)","key":"10.1016\/j.transci.2019.03.013_bib0115","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/jth.13005","article-title":"Factor XI and contact activation as targets for antithrombotic therapy","volume":"13","author":"Gailani","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"October (17)","key":"10.1016\/j.transci.2019.03.013_bib0120","first-page":"24","article-title":"The factor XIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activities","volume":"3","author":"Worm","year":"2015","journal-title":"Ann Transl Med"},{"issue":"January (1)","key":"10.1016\/j.transci.2019.03.013_bib0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/ATVBAHA.116.308595","article-title":"Factor XII as a therapeutic target in thromboembolic and inflammatory diseases","volume":"37","author":"Nickel","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"August (3)","key":"10.1016\/j.transci.2019.03.013_bib0130","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1046\/j.1432-1327.1999.00593.x","article-title":"Fibrinolytic properties of activated FXII","volume":"263","author":"Braat","year":"1999","journal-title":"Eur J Biochem"},{"issue":"June (6)","key":"10.1016\/j.transci.2019.03.013_bib0135","first-page":"1055","article-title":"The role of factor XI in a dilute thromboplastin assay of extrinsic coagulation pathway","volume":"85","author":"He","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.transci.2019.03.013_bib0140","series-title":"The mechanism of activation of the contact system and fibrinolytic system","author":"Coen Maas","year":"2008"},{"issue":"April (15)","key":"10.1016\/j.transci.2019.03.013_bib0145","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1182\/blood-2010-07-290551","article-title":"Histidine-rich glycoprotein binds factor XIIa with high affinity and inhibits contact-initiated coagulation","volume":"117","author":"MacQuarrie","year":"2011","journal-title":"Blood"},{"issue":"May","key":"10.1016\/j.transci.2019.03.013_bib0150","first-page":"215","article-title":"Complement-coagulation cross-talk: a potential mediator of the physiological activation of complement by low pH","volume":"6","author":"Kenawy","year":"2015","journal-title":"Front Immunol"},{"issue":"Jun (Suppl 1)","key":"10.1016\/j.transci.2019.03.013_bib0155","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1111\/jth.12950","article-title":"Reincarnation of ancient links between coagulation and complement","volume":"13","author":"Conway","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"October (2)","key":"10.1016\/j.transci.2019.03.013_bib0160","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12016-016-8540-0","article-title":"Bradykinin: inflammatory product of the coagulation system","volume":"51","author":"Hofman","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"issue":"Febuary (375)","key":"10.1016\/j.transci.2019.03.013_bib0165","article-title":"Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension","volume":"9","author":"Kossmann","year":"2017","journal-title":"Sci Transl Med"},{"issue":"September (5)","key":"10.1016\/j.transci.2019.03.013_bib0170","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/MOH.0000000000000363","article-title":"Single-chain factor XII: a new form of activated factor XII","volume":"24","author":"Ivanov","year":"2017","journal-title":"Curr Opin Hematol"},{"issue":"January (1)","key":"10.1016\/j.transci.2019.03.013_bib0175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/jth.14307","article-title":"Genetic determinants of activity and antigen levels of contact system factors","volume":"17","author":"Rohmann","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"32","key":"10.1016\/j.transci.2019.03.013_bib0180","doi-asserted-by":"crossref","first-page":"28498","DOI":"10.1074\/jbc.M203427200","article-title":"Activated platelets but not endothelial cells participate in the initiation of the consolidation phase of blood coagulation","volume":"277","author":"Regan Baird","year":"2002","journal-title":"J Biol Chem"},{"issue":"May(5)","key":"10.1016\/j.transci.2019.03.013_bib0185","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1538-7836.2010.03832.x","article-title":"Platelet polyphosphate: an endogenous activator of coagulation factor XII","volume":"8","author":"Mackman","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"July (7)","key":"10.1016\/j.transci.2019.03.013_bib0190","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/jth.12295","article-title":"Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates","volume":"11","author":"Puy","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"July(27)","key":"10.1016\/j.transci.2019.03.013_bib0195","doi-asserted-by":"crossref","first-page":"18655","DOI":"10.1074\/jbc.M802275200","article-title":"Factor XI homodimer StructureIs essential for normal proteolytic activation by factor XIIa,Thrombin, and FactorXIa","volume":"283","author":"Wu","year":"2008","journal-title":"J Biol Chem"},{"issue":"July (7)","key":"10.1016\/j.transci.2019.03.013_bib0200","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/jth.12275","article-title":"Analysis of the factor XI variant Arg184Gly suggests a structural basis for factor IX binding to factor XIa","volume":"11","author":"Geng","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"May (Suppl 2)","key":"10.1016\/j.transci.2019.03.013_bib0205","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S0049-3848(16)30354-1","article-title":"The hemostatic role of factor XI","volume":"141","author":"Puy","year":"2016","journal-title":"Thromb Res"},{"issue":"November (58)","key":"10.1016\/j.transci.2019.03.013_bib0210","article-title":"New tools to study contact activation","volume":"3","author":"Ros\u00e9n","year":"2016","journal-title":"Front Med (Lausanne)"},{"issue":"April (2)","key":"10.1016\/j.transci.2019.03.013_bib0215","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.transci.2017.03.004","article-title":"Blood derived products in pediatrics: new laboratory tools for optimizing potency assignment and reducing side effects","volume":"56","author":"Amiral","year":"2017","journal-title":"Transfus Apher Sci"},{"issue":"Febuary (6)","key":"10.1016\/j.transci.2019.03.013_bib0220","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1016\/S0021-9258(18)53549-3","article-title":"Identification and characterization of a binding site for factor XIIa in the Apple 4 domain of coagulation factor XI","volume":"268","author":"Baglia","year":"1993","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.transci.2019.03.013_bib0225","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000484257","article-title":"Kallikrein Cleaves C3 and activates complement","volume":"10","author":"Irmscher","year":"2018","journal-title":"J Innate Immun"},{"issue":"January (1)","key":"10.1016\/j.transci.2019.03.013_bib0230","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/01.ATV.19.1.170","article-title":"Thrombin activates factor XI on activated platelets in the absence of factor XII","volume":"19","author":"Oliver","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"July (2)","key":"10.1016\/j.transci.2019.03.013_bib0235","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1182\/blood-2010-10-312983","article-title":"Activation of factor XI by products of prothrombin activation","volume":"118","author":"Matafonov","year":"2011","journal-title":"Blood"},{"issue":"July(7)","key":"10.1016\/j.transci.2019.03.013_bib0240","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/j.1538-7836.2010.03899.x","article-title":"Coagulation procofactor activation by factor XIa","volume":"8","author":"Whelihan","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"December (12)","key":"10.1016\/j.transci.2019.03.013_bib0245","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1111\/jth.12435","article-title":"Evidence for factor IX-independent roles for factor XIa in blood coagulation","volume":"11","author":"Matafonov","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"Febuary(9)","key":"10.1016\/j.transci.2019.03.013_bib0250","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1182\/blood-2014-10-604587","article-title":"Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor","volume":"125","author":"Puy","year":"2015","journal-title":"Blood"},{"issue":"November (22)","key":"10.1016\/j.transci.2019.03.013_bib0255","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1182\/blood-2010-04-277798","article-title":"Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk","volume":"116","author":"Zhang","year":"2010","journal-title":"Blood"},{"issue":"March(10)","key":"10.1016\/j.transci.2019.03.013_bib0260","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1182\/blood-2011-10-387134","article-title":"Antisense inhibition of coagulation factor XI prolongs APTT without increased bleeding risk in cynomolgus monkeys","volume":"119","author":"Younis","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.transci.2019.03.013_bib0265","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1161\/ATVBAHA.113.301282","article-title":"Antithrombotic effect of antisense factor XI oligonucleotide treatment in Primates","volume":"33","author":"Crosby","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"December (12)","key":"10.1016\/j.transci.2019.03.013_bib0270","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/ajh.23559","article-title":"Hyperimmune globulins and same-day thrombotic adverse events as recorded in a large healthcare database during 2008-2011","volume":"88","author":"Menis","year":"2013","journal-title":"Am J Hematol"},{"issue":"December (6)","key":"10.1016\/j.transci.2019.03.013_bib0275","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/509899","article-title":"Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III","volume":"79","author":"Cichon","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"Supp 1","key":"10.1016\/j.transci.2019.03.013_bib0280","first-page":"1","article-title":"Evaluation of the fibrinolytic potential on plasma: physiological and pahological variations and association with cardiovascular diseases risk factors","volume":"13","author":"Amiral","year":"1999","journal-title":"Fibrinolysis Proteolysis"},{"issue":"May(18)","key":"10.1016\/j.transci.2019.03.013_bib0285","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1182\/blood-2013-11-462432","article-title":"Emerging roles for platelets as immune and inflammatory cells","volume":"123","author":"Morrell","year":"2014","journal-title":"Blood"},{"issue":"May (19)","key":"10.1016\/j.transci.2019.03.013_bib0290","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1182\/blood-2012-12-473629","article-title":"The dimeric structure of factor XI and zymogen activation","volume":"121","author":"Geng","year":"2013","journal-title":"Blood"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050219300242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050219300242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:49:47Z","timestamp":1761468587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050219300242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1473050219300242"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2019.03.013","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The contact system at the crossroads of various key patho- physiological functions: Update on present understanding, laboratory exploration and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2019.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}